| ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia JHA Martens, A Mandoli, F Simmer, BJ Wierenga, S Saeed, AA Singh, ... Blood, The Journal of the American Society of Hematology 120 (19), 4038-4048, 2012 | 116 | 2012 |
| CBFB–MYH11/RUNX1 together with a compendium of hematopoietic regulators, chromatin modifiers and basal transcription factors occupies self-renewal genes in inv (16) acute … A Mandoli, AA Singh, P Jansen, ATJ Wierenga, H Riahi, G Franci, ... Leukemia 28 (4), 770-778, 2014 | 86 | 2014 |
| Global fibroblast activation throughout the left ventricle but localized fibrosis after myocardial infarction CK Nagaraju, E Dries, N Popovic, AA Singh, P Haemers, HL Roderick, ... Scientific Reports 7 (1), 10801, 2017 | 73 | 2017 |
| The hematopoietic transcription factors RUNX1 and ERG prevent AML1-ETO oncogene overexpression and onset of the apoptosis program in t (8; 21) AMLs A Mandoli, AA Singh, KHM Prange, E Tijchon, M Oerlemans, R Dirks, ... Cell reports 17 (8), 2087-2100, 2016 | 67 | 2016 |
| E-cadherin loss induces targetable autocrine activation of growth factor signalling in lobular breast cancer K Teo, L Gómez-Cuadrado, M Tenhagen, A Byron, M Rätze, ... Scientific reports 8 (1), 15454, 2018 | 64 | 2018 |
| Optimized ChIP-seq method facilitates transcription factor profiling in human tumors AA Singh, K Schuurman, E Nevedomskaya, S Stelloo, S Linder, M Droog, ... Life science alliance 2 (1), e201800115, 2019 | 47 | 2019 |
| Chromatin-based classification of genetically heterogeneous AMLs into two distinct subtypes with diverse stemness phenotypes G Yi, ATJ Wierenga, F Petraglia, P Narang, EM Janssen-Megens, ... Cell reports 26 (4), 1059-1069. e6, 2019 | 37 | 2019 |
| AML associated oncofusion proteins PML-RARA, AML1-ETO and CBFB-MYH11 target RUNX/ETS-factor binding sites to modulate H3ac levels and drive leukemogenesis JHAM Abhishek A. Singh, Amit Mandoli, Koen H.M. Prange, Marko Laakso Oncotarget, 2017 | 24 | 2017 |
| The genome-wide molecular signature of transcription factors in leukemia KHM Prange, AA Singh, JHA Martens Experimental hematology 42 (8), 637-650, 2014 | 20 | 2014 |
| Multi-omics profiling reveals a distinctive epigenome signature for high-risk acute promyelocytic leukemia AA Singh, F Petraglia, A Nebbioso, G Yi, M Conte, S Valente, A Mandoli, ... Oncotarget 9 (39), 25647, 2018 | 15 | 2018 |
| Hindi-English neural machine translation using attention model C Verma, A Singh, S Seal, V Singh, I Mathur Int. J. Sci. Technol. Res 8 (11), 2019 | 6 | 2019 |
| Development of part of speech tagger using deep learning A Singh, C Verma, S Seal, V Singh Int J Eng Adv Technol 9 (1), 3384-91, 2019 | 5 | 2019 |
| Combined HAT/EZH2 modulation leads to cancer-selective cell death F Petraglia, AA Singh, V Carafa, A Nebbioso, M Conte, L Scisciola, ... Oncotarget 9 (39), 25630, 2018 | 5 | 2018 |
| Cataloguing functionally relevant polymorphisms in gene DNA ligase I: a computational approach AA Singh, D Sivakumar, P Somvanshi 3 Biotech 1, 47-56, 2011 | 5 | 2011 |
| Comparative analysis of neutrophil and monocyte epigenomes D Rico, JHA Martens, K Downes, E Carrillo-de-Santa-Pau, V Pancaldi, ... BioRxiv, 237784, 2017 | 4 | 2017 |
| Discovery of fluorinated 2‑Styryl 4 (3H)-quinazolinone as potential therapeutic hit for oral cancer DP Satpute, U Shirwadkar, AK Tharalla, SD Shinde, GN Vaidya, S Joshi, ... Bioorganic & Medicinal Chemistry 81, 117193, 2023 | 1 | 2023 |
| Bioinformatics: A brief introduction to changing trends in modern biology A Singh, P Somvanshi OMICS: Biomedical perspectives and applications, 23-39, 2011 | 1 | 2011 |
| Performance of crossbred base population in four regions to evolve" Frieswal" strain/breed of cattle in India. CL Arora, A Singh, RN Singh, RA Sinhal, RC Garg | 1 | 1993 |
| BM-MSC-Loaded Graphene-Collagen Cryogels Ameliorate Neuroinflammation in a Rat Spinal Cord Injury Model G Agarwal, A Roy, AA Singh, H Kumar, A Mandoli, A Srivastava ACS Applied Bio Materials, 2024 | | 2024 |
| Enhancer plasticity in endometrial tumorigenesis demarcates non-coding driver mutations and alterations in 3D genome organization to stimulate oncogene expression S Gregoricchio, A Kojic, M Hoogstraat, K Schuurman, S Stelloo, ... bioRxiv, 2023.07. 25.550368, 2023 | | 2023 |
